You are here

Novo Nordisk

Targeting Novo Nordisk in China's obesity market with a unique proposition, LeaderMed eyes US IPO

Fierce Biotech

Fri, 09/2/22 - 12:32 pm

Novo Nordisk to acquire Forma Therapeutics in $1.1. bln deal

Yahoo/Reuters

Thu, 09/1/22 - 10:49 am

Forma Therapeutics

blood disorders

ESC 2022 – Novo’s cardiovascular charge continues

EP Vantage

Thu, 09/1/22 - 10:13 am

A pharmaceutical jack of all trades? Novo CEO touts semaglutide's potential in NASH, Alzheimer's and its hot start in obesity

Fierce Pharma

Mon, 08/29/22 - 10:40 am

Alzheimer's disease

Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes

Yahoo Finance

Mon, 08/22/22 - 10:00 am

clinical trials

type 2 diabetes

Amid Wegovy's supply woes, Novo Nordisk sees surging demand for its original obesity drug Saxenda

Fierce Pharma

Thu, 08/4/22 - 11:05 am

drug manufacturing

Novo Nordisk's once-weekly insulin marches on after hitting goals in pair of phase 3 trials

Fierce Biotech

Fri, 07/29/22 - 09:54 am

clinical trials

Novo Nordisk, Eli Lilly poised to divvy up obesity market that could be worth $50B in 2030: analysts

Fierce Pharma

Sun, 07/17/22 - 11:07 pm

Marinus Pharma Shares Up After Deal for Rare Pediatric Disease Priority Review Voucher

Morningstar

Thu, 07/14/22 - 10:49 am

Marinus Pharmaceuticals

priority review vouchers

Vivus’ Qsymia beats out weight loss competitors in pricing watchdog's latest cost-effectiveness analysis

Endpoints

Wed, 07/13/22 - 08:22 pm

Novo Nordisk A/S: Phase 3 data for concizumab show 86% reduction in treated bleeds in haemophilia A or B with inhibitors

Yahoo Finance

Sun, 07/10/22 - 11:51 pm

Novo Nordisk workers in Korea protest after breakdown in salary and perks negotiations — report

Endpoints

Thu, 07/7/22 - 06:24 pm

After phase 2 flop, Novo Nordisk says its NASH work is 'still very much on track'

Fierce Pharma

Wed, 06/29/22 - 05:43 pm

Innovent catching up with Lilly, Novo Nordisk thanks to phase 2 obesity data

Fierce Biotech

Wed, 06/8/22 - 10:34 am

clinical trials

Novo Scores Phase III Insulin Win, Potentially Strengthening Market Position

BioSpace

Sun, 06/5/22 - 11:38 pm

clinical trials

Eli Lilly, Novo Nordisk and Sanofi face new lawsuit from Arkansas AG over insulin prices

Fierce Pharma

Thu, 05/12/22 - 10:54 pm

How Novo Nordisk Will Protect Insulin Sales

Motley Fool

Thu, 05/12/22 - 10:27 am

Affordable Insulin Now Act

Novo Nordisk forges close ties with biotech VC Flagship

Pharmaforum

Wed, 05/11/22 - 10:39 am

Flagship Pioneering

venture capital

Novo's Wegovy supply rebound on track for later this year as demand stays strong

Fierce Pharma

Mon, 05/2/22 - 11:04 am

Novo Nordisk once-weekly insulin clears first phase 3 test

Pharmaforum

Fri, 04/29/22 - 10:33 am

type 2 diabetes

once-weekly insulin

clinical trials

Pages